BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

730 related articles for article (PubMed ID: 12093317)

  • 1. Esomeprazole: a review of its use in the management of acid-related disorders.
    Scott LJ; Dunn CJ; Mallarkey G; Sharpe M
    Drugs; 2002; 62(10):1503-38. PubMed ID: 12093317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esomeprazole: a review of its use in the management of acid-related disorders in the US.
    Scott LJ; Dunn CJ; Mallarkey G; Sharpe M
    Drugs; 2002; 62(7):1091-118. PubMed ID: 11985491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of esomeprazole in the treatment of acid disorders.
    Johnson DA
    Expert Opin Pharmacother; 2003 Feb; 4(2):253-64. PubMed ID: 12562316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esomeprazole.
    Spencer CM; Faulds D
    Drugs; 2000 Aug; 60(2):321-9; discussion 330-1. PubMed ID: 10983736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost effectiveness of proton pump inhibitors in gastro-oesophageal reflux disease without oesophagitis: comparison of on-demand esomeprazole with conventional omeprazole strategies.
    Wahlqvist P; Junghard O; Higgins A; Green J
    Pharmacoeconomics; 2002; 20(4):267-77. PubMed ID: 11950383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lansoprazole: an update of its place in the management of acid-related disorders.
    Matheson AJ; Jarvis B
    Drugs; 2001; 61(12):1801-33. PubMed ID: 11693467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Race affects healing of erosive oesophagitis in patients treated with proton pump inhibitors.
    Sharma P; Johnson DA; Monyak JT; Illueca M
    Aliment Pharmacol Ther; 2011 Aug; 34(4):487-93. PubMed ID: 21682754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid symptom relief in reflux oesophagitis: a comparison of lansoprazole and omeprazole.
    Mee AS; Rowley JL
    Aliment Pharmacol Ther; 1996 Oct; 10(5):757-63. PubMed ID: 8899084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The new proton pump inhibitor esomeprazole is effective as a maintenance therapy in GERD patients with healed erosive oesophagitis: a 6-month, randomized, double-blind, placebo-controlled study of efficacy and safety.
    Vakil NB; Shaker R; Johnson DA; Kovacs T; Baerg RD; Hwang C; D'Amico D; Hamelin B
    Aliment Pharmacol Ther; 2001 Jul; 15(7):927-35. PubMed ID: 11421866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rabeprazole: an update of its use in acid-related disorders.
    Carswell CI; Goa KL
    Drugs; 2001; 61(15):2327-56. PubMed ID: 11772142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs.
    Langtry HD; Wilde MI
    Drugs; 1998 Sep; 56(3):447-86. PubMed ID: 9777317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of esomeprazole in patients with acid-peptic disorders.
    Beck J
    Gastroenterol Nurs; 2004; 27(2):44-9. PubMed ID: 15082946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial.
    Richter JE; Kahrilas PJ; Johanson J; Maton P; Breiter JR; Hwang C; Marino V; Hamelin B; Levine JG;
    Am J Gastroenterol; 2001 Mar; 96(3):656-65. PubMed ID: 11280530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pantoprazole: an update of its pharmacological properties and therapeutic use in the management of acid-related disorders.
    Cheer SM; Prakash A; Faulds D; Lamb HM
    Drugs; 2003; 63(1):101-33. PubMed ID: 12487624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lansoprazole for maintenance of remission of erosive oesophagitis.
    Freston JW; Jackson RL; Huang B; Ballard ED
    Drugs; 2002; 62(8):1173-84. PubMed ID: 12010078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders.
    Fitton A; Wiseman L
    Drugs; 1996 Mar; 51(3):460-82. PubMed ID: 8882382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost effectiveness of esomeprazole compared with omeprazole in the acute treatment of patients with reflux oesophagitis in the UK.
    Wahlqvist P; Junghard O; Higgins A; Green J
    Pharmacoeconomics; 2002; 20(4):279-87. PubMed ID: 11950384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rabeprazole: a review of its use in acid-related gastrointestinal disorders.
    Langtry HD; Markham A
    Drugs; 1999 Oct; 58(4):725-42. PubMed ID: 10551440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: esomeprazole, 40 mg once daily, compared with lansoprazole, 30 mg once daily, in healing and symptom resolution of erosive oesophagitis.
    Vakil N
    Aliment Pharmacol Ther; 2003 Feb; 17 Suppl 1():21-3. PubMed ID: 12614303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lansoprazole: in the treatment of gastro-oesophageal reflux disease in children and adolescents.
    Croom KF; Scott LJ
    Drugs; 2005; 65(15):2129-35; discussion 2136-7. PubMed ID: 16225368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.